DiaMedica Therapeutics Inc.

NasdaqCM:DMAC Stock Report

Market Cap: US$113.9m

DiaMedica Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:DMAC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Nov 23BuyUS$49,200David WambekeIndividual20,000US$2.46
23 Jun 23BuyUS$150,003David WambekeIndividual38,364US$3.91
23 Jun 23BuyUS$39,100Scott KellenIndividual10,000US$3.91
23 Jun 23BuyUS$49,997Dietrich PaulsIndividual12,787US$3.91
23 Jun 23BuyUS$149,999Richard PilnikIndividual38,363US$3.91
23 Jun 23BuyUS$254,150R. GiuffreIndividual65,000US$3.91
23 Jun 23BuyUS$49,997Charles SembaIndividual12,787US$3.91
23 Jun 23BuyUS$4,999,999Thomas von KochIndividual1,470,588US$3.40
23 Jun 23BuyUS$4,999,999Jan StahlbergIndividual1,470,588US$3.40
23 Jun 23BuyUS$4,999,999Thomas von KochIndividual1,470,588US$3.40

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of DMAC?
Owner TypeNumber of SharesOwnership Percentage
Private Companies7,2640.0191%
Institutions4,000,45210.5%
Individual Insiders14,132,71037.2%
General Public19,817,57452.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 43.5%.


Top Shareholders

Top 25 shareholders own 47.22% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12%
Richard Jacinto
4,558,823US$13.7m0%no data
11.4%
Thomas von Koch
4,326,435US$13.0m0%no data
10.6%
Jan Stahlberg
4,021,608US$12.1m0%no data
2.33%
Omega Advisors, Inc.
883,623US$2.7m0.87%0.1%
2.11%
The Vanguard Group, Inc.
802,171US$2.4m1.7%no data
1.39%
David Wambeke
527,114US$1.6m3.94%no data
1.32%
Paragon Associates, Ltd.
500,000US$1.5m6.38%2.87%
0.85%
R. Giuffre
322,893US$968.7k0%no data
0.76%
Altium Capital Management LP
287,698US$863.1k-42%0.42%
0.59%
Bleichroeder LP
222,317US$666.9k0%0.13%
0.58%
Geode Capital Management, LLC
218,778US$656.3k0%no data
0.44%
Jacob Asset Management of New York LLC
168,730US$506.2k0%0.52%
0.37%
Richard Pilnik
141,453US$424.4k0%no data
0.35%
Northern Trust Global Investments
133,633US$400.9k49%no data
0.32%
Morgan Stanley, Investment Banking and Brokerage Investments
120,995US$363.0k29%no data
0.3%
First Manhattan Co. LLC
114,744US$344.2k0%no data
0.28%
Aristides Capital LLC
106,333US$319.0k0%0.14%
0.28%
BlackRock, Inc.
104,732US$314.2k2.96%no data
0.26%
Timothy Lynch
100,259US$300.8k0%no data
0.18%
Dietrich Pauls
66,842US$200.5k-2.55%no data
0.18%
State Street Global Advisors, Inc.
66,629US$199.9k0%no data
0.096%
Catalyst Financial Partners LLC
36,267US$108.8k0%0.02%
0.085%
Scott Kellen
32,290US$96.9k0%no data
0.079%
Charles Semba
29,943US$89.8k75.4%no data
0.076%
Millennium Management LLC
28,845US$86.5k0.6%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.